Below are the most recent publications written about "Receptors, Calcitonin Gene-Related Peptide" by people in Profiles.
-
Navratilova E, Kopruszinski CM, Oyarzo J, Barber KR, Anderson T, Dodick DW, Schwedt TJ, Porreca F. Sex differences in effectiveness of CGRP receptor antagonism for treatment of acute and persistent headache-like pain in a mouse model of mild traumatic brain injury. Cephalalgia. 2025 02; 45(2):3331024251321087.
-
Alabbad S, Figueredo N, Yuan H, Silberstein S. Developments in targeting calcitonin gene-related peptide. Expert Rev Neurother. 2024 05; 24(5):477-485.
-
Chhabra N, Mead-Harvey C, Dodoo CA, Iser C, Taylor H, Chaudhary H, Vanood A, Dodick DW. Blood pressure elevation in erenumab-treated patients with migraine: A retrospective real-world experience. Headache. 2024 03; 64(3):233-242.
-
Ashina M, Hoffmann J, Ashina H, Hay DL, Flores-Montanez Y, Do TP, De Icco R, Dodick DW. Pharmacotherapies for Migraine and Translating Evidence From Bench to Bedside. Mayo Clin Proc. 2024 02; 99(2):285-299.
-
George N, Tepper SJ. Novel Migraine Treatments: A Review J Oral Facial Pain Headache. 2023; 37(1):25-32.
-
Ailani J, Kaiser EA, Mathew PG, McAllister P, Russo AF, V?lez C, Ramajo AP, Abdrabboh A, Xu C, Rasmussen S, Tepper SJ. Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine-Clinical Considerations: A Narrative Review. Neurology. 2022 11 07; 99(19):841-853.
-
Cohen F, Yuan H, Silberstein SD. Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale. BioDrugs. 2022 May; 36(3):341-358.
-
Tepper SJ, Sheikh HU, Dougherty CO, Nahas SJ, Winner PK, Karanam AK, Blumenfeld AM, Abdrabboh A, Rasmussen S, Weiss JL, Ailani J. Erenumab dosage for migraine prevention: An evidence-based narrative review with recommendations. Headache. 2022 04; 62(4):420-435.
-
Kopruszinski CM, Navratilova E, Swiokla J, Dodick DW, Chessell IP, Porreca F. A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain. Cephalalgia. 2021 03; 41(3):305-317.
-
Ceriani CEJ, Wilhour DA, Silberstein SD. Novel Medications for the Treatment of Migraine. Headache. 2019 10; 59(9):1597-1608.